Discover the detailed record of transactions filed by Waynick Denelle J, Director. Director active across 1 companies, notably Zogenix, INC.. Aggregated, 3 filings have been published. Total volume traded: €16k. The latest transaction was disclosed on 1 June 2021 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
3 of 3 declarations
Waynick Denelle J is a Board Member at Zogenix, Inc. He plays a key role in the governance of the company, contributing to strategic decision-making and the overall direction of the organization. Zogenix, Inc. specializes in developing treatments for neurological diseases. As a Board Member, Waynick brings his expertise and experience to help guide the company toward its growth and innovation objectives.